4.2 Review

Neuromodulation Interventions for the Treatment of Painful Diabetic Neuropathy: a Systematic Review

期刊

CURRENT PAIN AND HEADACHE REPORTS
卷 26, 期 5, 页码 365-377

出版社

SPRINGER
DOI: 10.1007/s11916-022-01035-9

关键词

Painful diabetic neuropathy; Spinal cord stimulation; Chronic pain; Diabetes mellitus; Neuromodulation; Neuropathic pain

向作者/读者索取更多资源

Painful diabetic neuropathy is a prevalent and debilitating condition characterized by severe pain, poor quality of life, and various physical and psychological issues. Recent studies have found that 10-kHz and tonic spinal cord stimulation can help alleviate pain and improve patient satisfaction, while evidence for other neuromodulation interventions is limited.
Purpose of Review Painful diabetic neuropathy (PDN) is a prevalent and debilitating condition, characterized by severe burning, tingling, and lancinating pain usually located in the distal lower extremities. In addition to manifesting with severe pain, PDN may also be associated with poor quality of life and sleep, mood disorders, burns, falls, and social withdrawal. The authors appraised the current body of literature for evidence on neuromodulation interventions for PDN. Recent Findings In patients with refractory PDN unresponsive to conventional medical management (glucose optimization and oral analgesic medications), there is level I evidence supporting the use of 10-kHz and tonic dorsal column spinal cord stimulation (SCS). Included studies reported significant associations between 10-kHz and tonic dorsal column SCS and superior analgesic outcomes, physical functioning, and patient satisfaction. Current level of evidence remains limited for other modalities of neuromodulation for PDN including burst SCS (level II-3), dorsal root ganglion SCS (level III), and peripheral nerve stimulation (level II-3). Some studies reported improvements in neurological physical examination, sensory testing, and/or reflex testing in patients undergoing 10-kHz SCS for treatment of PDN. In summary, the purpose of this review is to equip provider with important updates on the use of neuromodulation interventions for the treatment of PDN that is refractory to conventional medical therapy, with current level I evidence supporting use of 10-kHz and tonic SCS for PDN.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据